Sanofi India Limited has announced its 70th Annual General Meeting (AGM) scheduled for Wednesday, April 29, 2026 at 3:30 PM IST. The meeting will be conducted through video conferencing and other audio-visual means facility, in compliance with regulatory guidelines.

Regulatory Compliance and Publication

The company has fulfilled its regulatory obligations by publishing newspaper advertisements in Business Standard (English) and Sakal (Marathi) on April 3, 2026. This publication was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as confirmed by Company Secretary Haresh Vala in the official communication to stock exchanges.

Meeting Agenda and Key Business Items

The AGM will address both ordinary and special business matters crucial to the company's operations. The ordinary business includes adoption of audited financial statements for the financial year ended December 31, 2025, dividend matters, and director re-appointments.

Dividend Proposals

The company will seek confirmation of interim dividend payment of ₹75 per equity share and declaration of final dividend of ₹48 per equity share for the financial year ended December 31, 2025.

Director Appointments and Re-appointments

The meeting will address several key leadership changes:

Re-appointments:

• Mr. Vaibhav Karandikar (DIN: 09049375) - retiring by rotation
• Mr. Eric Mansion (DIN: 10654588) - retiring by rotation

New Appointments:

• Ms. Sudipta Chakraborty (DIN: 07166912) as Director and Whole-time Director for three years from March 1, 2026 to February 28, 2029
• Mrs. Rajani Kesari (DIN: 02384170) as Independent Director for five years from April 1, 2026 to March 31, 2031
• Mr. Siraj Azmat Chaudhry (DIN: 00161853) as Independent Director for five years from April 1, 2026 to March 31, 2031

Material Related Party Transactions

The company seeks approval for significant related party transactions expected to exceed materiality thresholds:

These transactions represent 75.38% and 28.85% of the company's annual turnover respectively for the preceding financial year.

Cost Auditor Remuneration

Shareholders will ratify the appointment and remuneration of M/s. Kishore Bhatia & Associates as Cost Auditors for the financial year ending December 31, 2026, with remuneration of ₹4,60,000 plus applicable taxes and out-of-pocket expenses.

Meeting Participation Guidelines

The AGM will accommodate 1,000 members on a first-come, first-served basis through video conferencing. Remote e-voting will be available from Saturday, April 25, 2026 at 9:00 AM to Tuesday, April 28, 2026 at 5:00 PM. The cut-off date for determining voting eligibility is Wednesday, April 22, 2026.

Members can access the complete notice and annual report through the company's website and stock exchange portals. The company has appointed Mr. Gaurav Sainani or Mr. Sunny Gogiya from M/s. SGGS and Associates as scrutinizers for the voting process.

Sanofi India Limited has issued comprehensive communication regarding Tax Deduction at Source (TDS) provisions for its final dividend of Rs. 48 per equity share for the financial year ended December 31, 2025. The communication, dated April 2, 2026, provides detailed guidelines for shareholders on TDS compliance and dividend payment procedures.

Final Dividend and Key Dates

The Board of Directors recommended the final dividend at their meeting held on February 25, 2026, subject to approval at the 70th Annual General Meeting scheduled for April 29, 2026. The company has established important dates for dividend eligibility and compliance:

TDS Provisions for Resident Shareholders

The company has outlined specific TDS requirements based on shareholder categories. For resident individual shareholders, no TDS will be deducted if the aggregate dividend during the tax year does not exceed Rs. 10,000 under section 393(1)(4) of the Income Tax Act, 2025.

Where valid PAN is available for resident individual shareholders, TDS will be deducted at 10% on dividend amounts. However, shareholders providing duly signed Form 121 in accordance with section 393(6) provisions may be eligible for no TDS deduction if eligibility conditions are met.

Non-Resident Shareholder Requirements

Non-resident shareholders face TDS deduction at 20% plus applicable surcharge and cess on dividend amounts. However, they may benefit from Double Tax Avoidance Treaty (DTAA) provisions if more favorable rates apply.

To avail DTAA benefits, non-resident shareholders must submit specific documentation:

Electronic Payment Mode and Compliance

Following SEBI regulations effective from November 19, 2025, dividend payments will be made exclusively through electronic modes including NEFT, RTGS, NECS, or other RBI-approved facilities. Physical dividend warrants and cheques have been discontinued.

Shareholders holding physical shares without updated PAN, nomination details, contact information, mobile numbers, bank account details, and specimen signatures will receive dividend payments only through electronic mode upon furnishing complete details to the company's Registrar and Transfer Agent, MUFG Intime India Private Limited.

Documentation and Submission Process

All shareholders must ensure their details are updated through their depository participant or with the RTA before the record date. The company requires residential status, valid PAN, shareholder category, email address, and complete residential address with postal code.

Document submissions must be made through the designated web portal at https://web.in.mpms.mufg.com/formsreg/submission-of-form-15g-15h.html by April 15, 2026, 5:00 pm IST. No communications regarding tax determination will be entertained after this deadline.

The company emphasizes that shareholders may file income tax returns and claim appropriate refunds if tax is deducted at higher rates due to insufficient documentation. All shareholders are advised to consult tax professionals for matters related to their specific tax situations.

Source: Company/INE058A01010/939e3a53-98a2-4e7c-a4b9-429a9825f0ee.pdf